How should I evaluate and manage a patient with brain fog, impaired executive function, fatigue, dizziness, and shortness of breath on standing or exertion, variable dysautonomia symptoms, a history of mold exposure in a manufactured home, a mild traumatic brain injury two years ago, and COVID‑19 infection four years ago?

Evaluation and Management of Post-COVID Dysautonomia with Environmental Triggers

This patient most likely has Long COVID with postural orthostatic tachycardia syndrome (POTS) and post-exertional malaise (PEM), compounded by environmental mold/VOC exposure that is exacerbating her symptoms. The improvement away from home strongly implicates the environmental trigger as a significant contributor, though the underlying Long COVID pathophysiology remains the primary driver 1.

Immediate Environmental Intervention

Remove the patient from the mold and VOC exposure immediately—this is non-negotiable. The clear temporal relationship between environmental exposure and symptom severity makes this the most modifiable factor affecting her quality of life. The manufactured home environment with mold, vinyl flooring, and wall-to-wall carpeting is creating a toxic exposure that compounds her post-viral dysautonomia 1.

Diagnostic Workup

Focus on tests that actually return abnormal results in Long COVID and dysautonomia, not the standard inflammatory markers that typically come back normal:

• Tilt table test or NASA lean test to confirm POTS (looking for heart rate increase ≥30 bpm within 10 minutes of standing) 1, 2
• Four-point salivary cortisol test (hypothalamus-pituitary-adrenal axis dysfunction is documented in Long COVID) 1
• Plasma catecholamines (particularly norepinephrine, which is excessively elevated in POTS and correlates with symptom severity) 3
• Small fiber neuropathy skin biopsy if available 1
• Cognitive testing including Trail Making Test Part A and B to objectively document executive dysfunction 4
• Inflammatory markers: IL-6, fibrinogen, ferritin (these DO correlate with executive dysfunction in Long COVID) 4

Skip the routine CBC, CRP, D-dimer, and ANA—these are typically normal in Long COVID and waste time 1.

Management Strategy

For POTS/Dysautonomia Symptoms

Start with non-pharmacological interventions first 1:

• Increase salt intake to 10-12 grams daily and fluid intake to 2-3 liters daily
• Compression stockings (waist-high, 30-40 mmHg)
• Water bolus therapy: 500 mL of water rapidly consumed can acutely reduce norepinephrine, decrease heart rate, and improve both symptoms and cognitive function for 1-2 hours 3

Pharmacological options (prioritize based on her symptom constellation) 1:

• β-blockers (propranolol or metoprolol) for tachycardia
• Pyridostigmine 30-60 mg TID (enhances acetylcholine, improves orthostatic tolerance)
• Fludrocortisone 0.1-0.2 mg daily (volume expansion)
• Midodrine 5-10 mg TID (peripheral vasoconstriction)

For Brain Fog and Executive Dysfunction

The evidence for specific treatments is limited, but the following have the strongest support 1:

• Cognitive pacing (similar to physical pacing—avoid cognitive overexertion)
• Post-concussion syndrome protocols (given her TBI history 2 years ago, this may have synergistic effects)
• Low-dose aripiprazole (1-2 mg daily) has shown benefit for fatigue, unrefreshing sleep, and brain fog in ME/CFS 1
• Coenzyme Q10 (200-400 mg daily) and D-ribose for mitochondrial support 1

Critical Management Principle: Avoid Exercise

Exercise is contraindicated and harmful in patients with post-exertional malaise 1. Physical activity worsened symptoms in 75% of Long COVID patients with PEM, and less than 1% improved. Instead, implement pacing strategies: stay within her energy envelope and avoid pushing through fatigue, as this triggers PEM and worsens dysautonomia.

Addressing the TBI Component

The mild TBI from 2 years ago may have created a vulnerability that COVID-19 exploited. Post-concussion syndrome and Long COVID share overlapping features (cognitive dysfunction, dysautonomia, fatigue). Use post-concussion protocols alongside Long COVID management 1.

Emerging Therapies to Consider

If standard treatments fail, discuss these options based on emerging evidence 1:

• Stellate ganglion block: Two case reports showed substantial improvement in dysautonomia symptoms (though effects may wane and require repeat procedures)
• Low-dose naltrexone (1.5-4.5 mg at bedtime): Substantial anecdotal success for pain, fatigue, and neurological symptoms
• Paxlovid: Case reports show resolution of Long COVID symptoms; worth considering if viral persistence is suspected

Common Pitfalls to Avoid

1. Do not prescribe graded exercise therapy or cognitive behavioral therapy as primary treatments—these are controversial and potentially harmful in ME/CFS-type presentations 1, 5

2. Do not dismiss symptoms as psychiatric—80% of POTS patients receive psychiatric misdiagnoses before correct diagnosis, and only 37% actually have psychiatric conditions once properly evaluated 1

3. Do not rely on standard inflammatory markers—they're typically normal in Long COVID despite significant pathology 1

4. Do not ignore the environmental component—the mold/VOC exposure is a modifiable factor that's clearly worsening her condition

Prognosis Discussion

Cognitive impairment in Long COVID can persist for at least 2 years and may worsen over time (16% at 2 months vs 26% at 12 months in one study) 1. However, with proper environmental remediation, dysautonomia management, and activity pacing, many patients see significant improvement. The key is preventing PEM cycles that perpetuate the condition.

The variable nature of her symptoms (some days markedly worse than others) is characteristic of POTS and suggests that with proper management—particularly addressing the environmental triggers and implementing POTS-specific interventions—substantial improvement is achievable 2, 3.